Inovio Pharmaceuticals Inc New (INO) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

Form 424B5 - Prospectus [Rule 424(b)(5)]

INOVIO Announces Pricing of $30 Million Public Offering

INOVIO Announces Pricing of $30 Million Public Offering PR Newswire PLYMOUTH MEETING, Pa., Dec. 13, 2024...

Form 424B5 - Prospectus [Rule 424(b)(5)]

INOVIO Announces Proposed Public Offering

INOVIO Announces Proposed Public Offering PR Newswire PLYMOUTH MEETING, Pa., Dec. 12, 2024 PLYMOUTH MEETING...

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial

New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When...

INOVIO Reports Inducement Grant Under Inducement Plan

INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Nov. 29, 2024...

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights

INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights PR Newswire PLYMOUTH...

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial

Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue...

INOVIO to Present at Upcoming Scientific Conferences

INOVIO to Present at Upcoming Scientific Conferences PR Newswire PLYMOUTH MEETING, Pa., Nov. 6, 2024 PLYMOUTH...

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024

INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024 PR Newswire PLYMOUTH MEETING, Pa...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP

INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for...

INOVIO Reports Inducement Grants Under Inducement Plan

INOVIO Reports Inducement Grants Under Inducement Plan PR Newswire PLYMOUTH MEETING, Pa., Oct. 2, 2024...